Fingolimod Lauryl Sulfate Patent Expiration
Fingolimod Lauryl Sulfate is Used for treating relapsing forms of multiple sclerosis in pediatric patients 10 years of age and older. It was first introduced by Cycle Pharmaceuticals Ltd
Fingolimod Lauryl Sulfate Patents
Given below is the list of patents protecting Fingolimod Lauryl Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tascenso Odt | US10555902 | Stable fingolimod dosage forms | Jan 19, 2036 | Cycle |
| Tascenso Odt | US10925829 | Stable solid fingolimod dosage forms | Jan 19, 2036 | Cycle |
| Tascenso Odt | US9925138 | Stable solid fingolimod dosage forms | Jan 19, 2036 | Cycle |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Fingolimod Lauryl Sulfate's patents.
Latest Legal Activities on Fingolimod Lauryl Sulfate's Patents
Given below is the list recent legal activities going on the following patents of Fingolimod Lauryl Sulfate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 05 Jul, 2023 | US10555902 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 25 Jun, 2021 | US9925138 |
| Recordation of Patent Grant Mailed Critical | 23 Feb, 2021 | US10925829 |
| Patent Issue Date Used in PTA Calculation Critical | 23 Feb, 2021 | US10925829 |
| Email Notification Critical | 04 Feb, 2021 | US10925829 |
| Issue Notification Mailed Critical | 03 Feb, 2021 | US10925829 |
| Application Is Considered Ready for Issue Critical | 20 Jan, 2021 | US10925829 |
| Dispatch to FDC | 20 Jan, 2021 | US10925829 |
| Issue Fee Payment Received Critical | 19 Jan, 2021 | US10925829 |
| Issue Fee Payment Verified Critical | 19 Jan, 2021 | US10925829 |
Fingolimod Lauryl Sulfate's Family Patents
